Trump announces deals to cut weight loss drug prices and expand Medicare coverage
TL;DR Summary
The Trump administration announced deals with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 drugs for Americans, including Medicare beneficiaries, with prices starting at $150 for pills and $350 for injectables, aiming to expand access and reduce costs for obesity and diabetes treatments.
- Trump administration announces deal to lower weight loss drug prices for many Americans abcnews.go.com
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- President Trump on Lowering Price of Weight Loss Drugs C-SPAN
- Obesity Drugs May Drop to as Little as $150 a Month The New York Times
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
93%
684 → 46 words
Want the full story? Read the original article
Read on abcnews.go.com